Compare Stocks

→ His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DVCR Diversicare Healthcare Services	$10.09 +1.0%	$10.09	$2.50 ▼ $10.09	$70.12M	0.86	18,931 shs	49,400 shs
IMRX Immuneering	$1.47 +2.8%	$3.70	$1.40 ▼ $11.92	$43.59M	-0.89	546,555 shs	295,784 shs
PASG Passage Bio	$1.32 +8.2%	$1.38	$0.58 ▼ $1.79	$81.33M	1.3	126,621 shs	75,861 shs
PTWO Pono Capital Two	$14.99 +3.0%	$12.49	$10.15 ▼ $15.00	$78.19M	0.11	2,640 shs	236 shs

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DVCR Diversicare Healthcare Services	0.00%	0.00%	0.00%	0.00%	0.00%
IMRX Immuneering	0.00%	-18.33%	-49.13%	-76.14%	-86.65%
PASG Passage Bio	0.00%	+14.78%	-2.22%	+36.08%	+38.73%
PTWO Pono Capital Two	+9.02%	+22.77%	+19.92%	+38.41%	+43.86%

4 coins to be the “Next Bitcoin” (Ad)

The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…

Click For My #1 FREE Crypto for 2024

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DVCR Diversicare Healthcare Services	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
IMRX Immuneering	4.1487 of 5 stars	4.3	3.0	0.0	0.0	2.2	5.0	1.3
PASG Passage Bio	2.5402 of 5 stars	3.5	2.0	0.0	0.0	1.7	2.5	1.3
PTWO Pono Capital Two	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DVCR Diversicare Healthcare Services	N/A	N/A	N/A	N/A
IMRX Immuneering	2.50	Moderate Buy	$13.50	818.37% Upside
PASG Passage Bio	3.00	Buy	$9.33	607.07% Upside
PTWO Pono Capital Two	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest DVCR, IMRX, PTWO, and PASG Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/12/2024	IMRX Immuneering	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$15.00
4/2/2024	IMRX Immuneering	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$20.00 ➝ $8.00
3/15/2024	IMRX Immuneering	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$21.00 ➝ $16.00
3/15/2024	IMRX Immuneering	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$20.00 ➝ $15.00
3/15/2024	IMRX Immuneering	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Market Perform
3/15/2024	IMRX Immuneering	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$16.00 ➝ $3.00
3/14/2024	IMRX Immuneering	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Neutral
3/5/2024	IMRX Immuneering	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$25.00
3/5/2024	PASG Passage Bio	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$14.00
3/4/2024	IMRX Immuneering	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$20.00
2/1/2024	IMRX Immuneering	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$20.00

(Data available from 4/28/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DVCR Diversicare Healthcare Services	$475.72M	0.15	$5.87 per share	1.72	($4.57) per share	-2.21
IMRX Immuneering	$320K	136.20	N/A	N/A	$3.09 per share	0.48
PASG Passage Bio	N/A	N/A	N/A	N/A	$2.03 per share	N/A
PTWO Pono Capital Two	N/A	N/A	$0.10 per share	157.26	($1.68) per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DVCR Diversicare Healthcare Services	$5.16M	$0.36	28.03	∞	N/A	0.53%	-15.01%	1.05%	N/A
IMRX Immuneering	-$53.47M	-$1.89	N/A	N/A	N/A	N/A	-52.49%	-47.63%	5/2/2024 (Estimated)
PASG Passage Bio	-$102.06M	-$1.86	N/A	N/A	N/A	N/A	-73.12%	-56.17%	5/9/2024 (Estimated)
PTWO Pono Capital Two	$340K	N/A	0.00	∞	N/A	N/A	-6.63%	0.73%	N/A

Latest DVCR, IMRX, PTWO, and PASG Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/4/2024	Q4 2023	PASG Passage Bio	-$0.41	-$0.30	+$0.11	-$0.30	N/A	N/A
3/1/2024	12/31/2023	IMRX Immuneering	-$0.46	-$0.52	-$0.06	-$0.52	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DVCR Diversicare Healthcare Services	N/A	N/A	N/A	N/A	N/A
IMRX Immuneering	N/A	N/A	N/A	N/A	N/A
PASG Passage Bio	N/A	N/A	N/A	N/A	N/A
PTWO Pono Capital Two	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DVCR Diversicare Healthcare Services	N/A	0.83	0.83
IMRX Immuneering	N/A	11.35	11.35
PASG Passage Bio	N/A	7.22	7.22
PTWO Pono Capital Two	N/A	0.15	0.15

Ownership

Institutional Ownership

Company	Institutional Ownership
DVCR Diversicare Healthcare Services	33.14%
IMRX Immuneering	67.65%
PASG Passage Bio	53.48%
PTWO Pono Capital Two	60.82%

Insider Ownership

Company	Insider Ownership
DVCR Diversicare Healthcare Services	34.30%
IMRX Immuneering	23.00%
PASG Passage Bio	12.40%
PTWO Pono Capital Two	63.90%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
DVCR Diversicare Healthcare Services	3,750	6.95 million	4.57 million	Not Optionable
IMRX Immuneering	68	29.65 million	22.83 million	Not Optionable
PASG Passage Bio	58	61.61 million	53.97 million	Optionable
PTWO Pono Capital Two	N/A	5.22 million	1.88 million	Not Optionable

DVCR, IMRX, PTWO, and PASG Headlines

Source	Headline
	Pono Capital Two, Inc. (NASDAQ:PTWO) Major Shareholder Co. Ltd. Zuu Buys 2,615 Shares americanbankingnews.com - April 27 at 5:40 AM
	Pono Capital Two, Inc. (NASDAQ:PTWO) Major Shareholder Acquires $33,916.55 in Stock insidertrades.com - April 26 at 6:11 AM
	Co. Ltd. Zuu Buys 2,615 Shares of Pono Capital Two, Inc. (NASDAQ:PTWO) Stock marketbeat.com - April 25 at 10:16 PM
	Head-To-Head Contrast: Teladoc Health (NYSE:TDOC) versus Pono Capital Two (NASDAQ:PTWO) americanbankingnews.com - April 21 at 2:12 AM
	Co. Ltd. Zuu Purchases 19,236 Shares of Pono Capital Two, Inc. (NASDAQ:PTWO) Stock insidertrades.com - April 4 at 6:36 AM
	Insider Buying: Pono Capital Two, Inc. (NASDAQ:PTWO) Major Shareholder Buys 1,734 Shares of Stock insidertrades.com - March 22 at 10:47 AM
	Pono Capital Two, Inc. (NASDAQ:PTWO) Major Shareholder Purchases $21,972.00 in Stock insidertrades.com - March 14 at 10:28 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Diversicare Healthcare Services

OTCMKTS:DVCR

Diversicare Healthcare Services, Inc. provides post-acute care services. The firm offers services to patients and residents including skilled nursing, ancillary health care services and assisted living. It also provides long-term care centres and rehabilitative, nutritional, respiratory and other specialized ancillary services. The company was founded in 1994 and is headquartered in Brentwood, TN.

Immuneering

NASDAQ:IMRX

Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 is in Investigational New Drug application to treat solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.

Passage Bio

NASDAQ:PASG

Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; and PBKR03, a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other program for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. Passage Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.

Pono Capital Two

NASDAQ:PTWO

Pono Capital Two, Inc. does not have any significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Pono Capital Two, Inc. was incorporated in 2022 and is based in Honolulu, Hawaii.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial